ArticleJournal of cell science2026
Differential AXL expression and Arf1 regulation control stiffness-dependent Golgi organization in breast cancer cells.
Article in Journal of cell science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mechanical forces stimulate Golgi export.The Journal of cell biology · 2026Article
- AXL receptor tyrosine kinase regulates Golgi organization and function via an adhesion-Arf1 signalling axis in breast and lung cancer cell lines.Biology open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Integrin-mediated adhesion regulates cellular survival and mechanotransduction, processes often deregulated in cancers. During breast tumor progression, matrix stiffening influences cytoskeletal organization, although its effect on organelle organization and function remains unclear. Here, we examine how Golgi organization responds to matrix stiffness sensing in breast cancer cells. In adherent MDA-MB-231 cells, the Golgi becomes progressively more compact and organized with increasing matrix stiffness, accompanied by enhanced tubulin acetylation, indicating stiffness-dependent regulation. In contrast, MCF7 cells display a diffused or disorganized Golgi regardless of matrix stiffness. AXL, a receptor tyrosine kinase differentially expressed in MDA-MB-231 cells and absent in MCF7, localizes prominently to the Golgi. Inhibition or knockdown of AXL disrupted stiffness-dependent Golgi organization in MDA-MB-231 cells, whereas stable AXL expression in MCF7 restored Golgi organization at higher stiffness. A stiffness-dependent increase in AXL and Arf1 expression regulates Arf1 activation and localization to control mechanosensitive Golgi organization. Inhibition of AXL and/or Arf1 disrupted Golgi organization, tubulin acetylation and cell-surface glycosylation. Together, our findings reveal a mechanoresponsive AXL-Arf1-Golgi signaling axis that integrates matrix stiffness sensing with Golgi organization and function in breast cancer cells.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.